Literature DB >> 32687801

Lung recruitment before surfactant administration in extremely preterm neonates with respiratory distress syndrome (IN-REC-SUR-E): a randomised, unblinded, controlled trial.

Giovanni Vento1, Maria Luisa Ventura2, Roberta Pastorino3, Anton H van Kaam4, Virgilio Carnielli5, Filip Cools6, Carlo Dani7, Fabio Mosca8, Graeme Polglase9, Paolo Tagliabue2, Luca Boni10, Francesco Cota11, Milena Tana11, Chiara Tirone11, Claudia Aurilia11, Alessandra Lio11, Simonetta Costa11, Vito D'Andrea11, Mariella Lucente12, Gabriella Nigro12, Lucio Giordano13, Vincenzina Roma13, Paolo E Villani14, Francesca P Fusco15, Valeria Fasolato14, Maria Rosa Colnaghi8, Piero G Matassa8, Valentina Vendettuoli8, Chiara Poggi7, Antonio Del Vecchio16, Flavia Petrillo16, Pasqua Betta17, Carmine Mattia17, Giampaolo Garani18, Agostina Solinas18, Eloisa Gitto19, Vincenzo Salvo19, Giancarlo Gargano20, Eleonora Balestri20, Fabrizio Sandri21, Giovanna Mescoli21, Stefano Martinelli22, Laura Ilardi22, Elena Ciarmoli2, Sandra Di Fabio23, Eugenia Maranella23, Carolina Grassia24, Gaetano Ausanio24, Vincenzo Rossi24, Angela Motta25, Lucia G Tina25, Kim Maiolo25, Stefano Nobile26, Hubert Messner27, Alex Staffler27, Federica Ferrero28, Ilaria Stasi28, Luisa Pieragostini29, Isabella Mondello30, Cristina Haass31, Chiara Consigli31, Stefania Vedovato32, Alessandra Grison32, Gianfranco Maffei33, Giuseppe Presta34, Roberto Perniola34, Marcello Vitaliti35, Maria P Re35, Mario De Curtis36, Viviana Cardilli36, Paola Lago37, Francesca Tormena37, Luigi Orfeo38, Camilla Gizzi38, Luca Massenzi38, Diego Gazzolo39, Maria Chiara M Strozzi40, Roberto Bottino41, Federica Pontiggia41, Alberto Berardi42, Isotta Guidotti42, Caterina Cacace43, Valerio Meli43, Lorenzo Quartulli44, Antonio Scorrano44, Alessandra Casati45, Lidia Grappone46, J Jane Pillow47.   

Abstract

BACKGROUND: The importance of lung recruitment before surfactant administration has been shown in animal studies. Well designed trials in preterm infants are absent. We aimed to examine whether the application of a recruitment manoeuvre just before surfactant administration, followed by rapid extubation (intubate-recruit-surfactant-extubate [IN-REC-SUR-E]), decreased the need for mechanical ventilation during the first 72 h of life compared with no recruitment manoeuvre (ie, intubate-surfactant-extubate [IN-SUR-E]).
METHODS: We did a randomised, unblinded, controlled trial in 35 tertiary neonatal intensive care units in Italy. Spontaneously breathing extremely preterm neonates (24 + 0 to 27 + 6 weeks' gestation) reaching failure criteria for continuous positive airway pressure within the first 24 h of life were randomly assigned (1:1) with a minimisation algorithm to IN-REC-SUR-E or IN-SUR-E using an interactive web-based electronic system, stratified by clinical site and gestational age. The primary outcome was the need for mechanical ventilation in the first 72 h of life. Analyses were done in intention-to-treat and per-protocol populations, with a log-binomial regression model correcting for stratification factors to estimate adjusted relative risk (RR). This study is registered with ClinicalTrials.gov, NCT02482766.
FINDINGS: Of 556 infants assessed for eligibility, 218 infants were recruited from Nov 12, 2015, to Sept 23, 2018, and included in the intention-to-treat analysis. The requirement for mechanical ventilation during the first 72 h of life was reduced in the IN-REC-SUR-E group (43 [40%] of 107) compared with the IN-SUR-E group (60 [54%] of 111; adjusted RR 0·75, 95% CI 0·57-0·98; p=0·037), with a number needed to treat of 7·2 (95% CI 3·7-135·0). The addition of the recruitment manoeuvre did not adversely affect the safety outcomes of in-hospital mortality (19 [19%] of 101 in the IN-REC-SUR-E group vs 37 [33%] of 111 in the IN-SUR-E group), pneumothorax (four [4%] of 101 vs seven [6%] of 111), or grade 3 or worse intraventricular haemorrhage (12 [12%] of 101 vs 17 [15%] of 111).
INTERPRETATION: A lung recruitment manoeuvre just before surfactant administration improved the efficacy of surfactant treatment in extremely preterm neonates compared with the standard IN-SUR-E technique, without increasing the risk of adverse neonatal outcomes. The reduced need for mechanical ventilation during the first 72 h of life might facilitate implementation of a non-invasive respiratory support strategy. FUNDING: None.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32687801     DOI: 10.1016/S2213-2600(20)30179-X

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  11 in total

Review 1.  Insights Gained Into the Treatment of COVID19 by Pulmonary Surfactant and Its Components.

Authors:  Dan Li; Xianzheng Wang; Yingzhao Liao; Shouchuan Wang; Jinjun Shan; Jianjian Ji
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

2.  Short term outcomes of extremely low birth weight infants from a multicenter cohort study in Guangdong of China.

Authors:  Chun-Hong Jia; Zhou-Shan Feng; Sha-Sha Han; Chuan-Zhong Yang; Yi-Heng Dai; Xiu-Zhen Ye; Lu Ding; Hong-Xiang Chen; Zhe Zhang; Wei-Min Huang; Bing-Yan Yang; Le-Ying Huo; Hong-Ping Rao; Yong Yang; Dong Liu; Shi-Guang Diao; Chu-Ming You; Bin Wang; Yu-Ge Huang; Wei-Zhong Li; Yan-Ling Chen; Zhi-Feng Chen; Xiao-Yu Li; Ni-Yang Lin; Zhong-He Wan; Bo Bai; Yue-Xiu Yan; Xiao-Jun Lin; Qi-Liang Cui; Ya Jin; Guo-Sheng Liu; Xiao-Tong Ye; Wei-Yi Liang; Jing Mo; Ben-Qing Wu; Chi-Wang Li; Xiao Rong; Wei Shen; Jun-Feng Lv; Hui-Wen Huang; Wen-Kang Yan; Xue-Jun Ren; Fang-Fang Wang; Xiao-Yan Liu; Qiong Meng; Li-Juan Zhang; Dang Ao; Jie-Ling Chen; Wei Li; Yue-Qin Ding; Yue-Fang Huang; Yang-Fan Cai; Yi Ban; Guang-Hong Li; Fan Wu
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

3.  Lung recruitment manoeuvres for reducing mortality and respiratory morbidity in mechanically ventilated neonates.

Authors:  Elizabeth V Blazek; Christine E East; Jacqueline Jauncey-Cooke; Fiona Bogossian; Caroline A Grant; Judith Hough
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

4.  Association of Adherence to Surfactant Best Practice Uses With Clinical Outcomes Among Neonates in Sweden.

Authors:  Pontus Challis; Per Nydert; Stellan Håkansson; Mikael Norman
Journal:  JAMA Netw Open       Date:  2021-05-03

Review 5.  Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants.

Authors:  Tobias Muehlbacher; Dirk Bassler; Manuel B Bryant
Journal:  Children (Basel)       Date:  2021-04-13

6.  Effects of High-Frequency Oscillatory Ventilation With Volume Guarantee During Surfactant Treatment in Extremely Low Gestational Age Newborns With Respiratory Distress Syndrome: An Observational Study.

Authors:  Milena Tana; Angela Paladini; Chiara Tirone; Claudia Aurilia; Alessandra Lio; Anthea Bottoni; Simonetta Costa; Eloisa Tiberi; Roberta Pastorino; Giovanni Vento
Journal:  Front Pediatr       Date:  2022-03-03       Impact factor: 3.418

7.  Roles of Lung Ultrasound Score in the Extubation Failure From Mechanical Ventilation Among Premature Infants With Neonatal Respiratory Distress Syndrome.

Authors:  Zhenyu Liang; Qiong Meng; Chuming You; Bijun Wu; Xia Li; Qianmei Wu
Journal:  Front Pediatr       Date:  2021-12-06       Impact factor: 3.418

Review 8.  The non-specific and sex-differential effects of vaccines.

Authors:  Peter Aaby; Christine Stabell Benn; Katie L Flanagan; Sabra L Klein; Tobias R Kollmann; David J Lynn; Frank Shann
Journal:  Nat Rev Immunol       Date:  2020-05-27       Impact factor: 53.106

9.  Alternative Methods of Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome: State of the Art.

Authors:  Ömer Erdeve; Emel Okulu; Kari D Roberts; Scott O Guthrie; Prem Fort; H Gözde Kanmaz Kutman; Peter A Dargaville
Journal:  Turk Arch Pediatr       Date:  2021-11

Review 10.  Update on ventilatory management of extremely preterm infants-A Neonatal Intensive Care Unit perspective.

Authors:  Sven M Schulzke; Benjamin Stoecklin
Journal:  Paediatr Anaesth       Date:  2021-12-15       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.